Opus Genetics, Stock Alpha and Beta Analysis
| IRD Stock | 1.11 0.06 5.71% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Opus Genetics,. It also helps investors analyze the systematic and unsystematic risks associated with investing in Opus Genetics, over a specified time horizon. Remember, high Opus Genetics,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Opus Genetics,'s market risk premium analysis include:
Beta 2.35 | Alpha (0.34) | Risk 4.74 | Sharpe Ratio 0.0004 | Expected Return 0.0018 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Opus |
Opus Genetics, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Opus Genetics, market risk premium is the additional return an investor will receive from holding Opus Genetics, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Opus Genetics,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Opus Genetics,'s performance over market.| α | -0.34 | β | 2.35 |
Opus Genetics, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Opus Genetics,'s Buy-and-hold return. Our buy-and-hold chart shows how Opus Genetics, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Opus Genetics, Market Price Analysis
Market price analysis indicators help investors to evaluate how Opus Genetics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Opus Genetics, shares will generate the highest return on investment. By understating and applying Opus Genetics, stock market price indicators, traders can identify Opus Genetics, position entry and exit signals to maximize returns.
Opus Genetics, Return and Market Media
The median price of Opus Genetics, for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 is 1.25 with a coefficient of variation of 9.59. The daily time series for the period is distributed with a sample standard deviation of 0.12, arithmetic mean of 1.22, and mean deviation of 0.09. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Insider Trading | 10/22/2024 |
2 | Shareholder Alert Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders | 10/23/2024 |
3 | The RD Fund Announces Ocuphire Pharmas Acquisition of Opus Genetics - StockTitan | 10/25/2024 |
4 | Disposition of 37050 shares by Magrath George of Opus Genetics, at 1.18 subject to Rule 16b-3 | 11/01/2024 |
5 | Acquisition by Yerxa Benjamin R of 332800 shares of Opus Genetics, subject to Rule 16b-3 | 11/07/2024 |
6 | Acquisition by Magrath George of 90294 shares of Opus Genetics, at 1.0102 subject to Rule 16b-3 | 11/15/2024 |
7 | Acquisition by Magrath George of 9706 shares of Opus Genetics, at 1.0244 subject to Rule 16b-3 | 11/18/2024 |
8 | Opus Genetics Inc CEO George Magrath Purchases 100,000 Shares | 11/20/2024 |
9 | Acquisition by Yerxa Benjamin R of 10000 shares of Opus Genetics, at 0.9834 subject to Rule 16b-3 | 11/21/2024 |
10 | Opus Genetics president Benjamin Yerxa acquires 9,834 in stock | 11/25/2024 |
About Opus Genetics, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Opus or other stocks. Alpha measures the amount that position in Opus Genetics, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Opus Genetics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Opus Genetics,'s short interest history, or implied volatility extrapolated from Opus Genetics, options trading.
Build Portfolio with Opus Genetics,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Opus Genetics, Backtesting, Opus Genetics, Valuation, Opus Genetics, Correlation, Opus Genetics, Hype Analysis, Opus Genetics, Volatility, Opus Genetics, History and analyze Opus Genetics, Performance. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Opus Genetics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.